VMD-928 is an orally active, allosteric, and irreversible inhibitor targeting tropomyosin receptor kinase A (TrkA). By blocking the downstream signaling pathways initiated by nerve growth factor (NGF) binding, VMD-928 inhibits cell proliferation and invasion while promoting cancer cell apoptosis. This compound is of significant interest in research related to various cancers, including prostate cancer, thymic carcinoma, mesothelioma, squamous cell carcinoma of the head and neck, lung squamous cell carcinoma, ovarian cancer, and hepatocellular carcinoma.
VMD-928 is an orally active, allosteric, and irreversible inhibitor targeting tropomyosin receptor kinase A (TrkA). By blocking the downstream signaling pathways initiated by nerve growth factor (NGF) binding, VMD-928 inhibits cell proliferation and invasion while promoting cancer cell apoptosis. This compound is of significant interest in research related to various cancers, including prostate cancer, thymic carcinoma, mesothelioma, squamous cell carcinoma of the head and neck, lung squamous cell carcinoma, ovarian cancer, and hepatocellular carcinoma.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
